Blood phenylalanine control in adolescents with phenylketonuria
- PMID: 15148857
- DOI: 10.1515/ijamh.2004.16.1.41
Blood phenylalanine control in adolescents with phenylketonuria
Abstract
In order to determine the degree of compliance with dietary treatment in adolescents with phenylketonuria (PKU) we have analysed blood phenylalanine (phe) results in 75 patients (42 male) aged between 10 and 20 years. We compared these results with the upper limit for blood phe and the blood sampling frequency as recommended by the United Kingdom's National Society for Phenylketonuria (NSPKU(UK)). The blood phe increased with age from a mean (1SD) of 0.51 mmol/l (0.19) at 10 years to 0.98 mmol/l (0.30) by 20 years. A mean of 17% (24) of samples were above the recommended range at 10 years, but this had increased to a mean of 75% (33) by 20 yrs. The frequency of blood sampling fell from a mean of 83% (32) of that recommended to under 51% (37) by 20 years. Control was not significantly better in females compared with males. We conclude that although compliance with treatment in PKU is acceptable for most patients at 10 years this is not the case by late adolescents and early adulthood.
Similar articles
-
Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?Nutrients. 2024 Jun 28;16(13):2064. doi: 10.3390/nu16132064. Nutrients. 2024. PMID: 38999811 Free PMC article.
-
An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria.Clin Biochem. 1996 Apr;29(2):133-8. doi: 10.1016/0009-9120(95)02033-0. Clin Biochem. 1996. PMID: 8601321
-
Work activity and phenylalanine levels in a population of young adults with classic PKU.Med Lav. 2017 Apr 21;108(2):118-122. doi: 10.23749/mdl.v108i2.5984. Med Lav. 2017. PMID: 28446738
-
Outcomes beyond phenylalanine: an international perspective.Mol Genet Metab. 2010;99 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2009.09.015. Mol Genet Metab. 2010. PMID: 20123476 Review.
-
Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.Mol Genet Metab. 2007 Sep-Oct;92(1-2):63-70. doi: 10.1016/j.ymgme.2007.05.006. Epub 2007 Jun 25. Mol Genet Metab. 2007. PMID: 17591452
Cited by
-
White matter integrity and executive abilities in individuals with phenylketonuria.Mol Genet Metab. 2013 Jun;109(2):125-31. doi: 10.1016/j.ymgme.2013.03.020. Epub 2013 Apr 6. Mol Genet Metab. 2013. PMID: 23608077 Free PMC article.
-
Implementing a Transition Program from Paediatric to Adult Services in Phenylketonuria: Results After Two Years of Follow-Up with an Adult Team.Nutrients. 2021 Feb 28;13(3):799. doi: 10.3390/nu13030799. Nutrients. 2021. PMID: 33671057 Free PMC article.
-
An Observational Study Evaluating the Introduction of a Prolonged-Release Protein Substitute to the Dietary Management of Children with Phenylketonuria.Nutrients. 2020 Sep 3;12(9):2686. doi: 10.3390/nu12092686. Nutrients. 2020. PMID: 32899129 Free PMC article.
-
'Ready to drink' protein substitute is easier is for people with phenylketonuria.J Inherit Metab Dis. 2006 Aug;29(4):526-31. doi: 10.1007/s10545-006-0234-y. Epub 2006 May 30. J Inherit Metab Dis. 2006. PMID: 16736099 Clinical Trial.
-
Development of an inventory to assess perceived barriers related to PKU treatment.J Patient Rep Outcomes. 2020 May 1;4(1):29. doi: 10.1186/s41687-020-00194-w. J Patient Rep Outcomes. 2020. PMID: 32358708 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical